CellaVision AB (publ)
CellaVision AB (publ) (CLVSF) Revenue
Annual & quarterly revenue history · segment & region breakdown
CLVSF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsCellaVision AB (publ) trailing twelve-month (TTM) revenue is $0.73B, an increase of 4.94% year-over-year from $0.76B in FY2025.
Revenue trend
2025 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.76B | +$0.04B | +4.94% |
| 2024-12-31 | $0.72B | +$0.05B | +6.78% |
| 2023-12-31 | $0.68B | +$0.04B | +5.94% |
| 2022-12-31 | $0.64B | +$0.07B | +13.05% |
| 2021-12-31 | $0.57B | +$0.09B | +19.96% |
| 2020-12-31 | $0.47B | +$0.01B | +2.09% |
| 2019-12-31 | $0.46B | +$0.10B | +26.58% |
| 2018-12-31 | $0.36B | +$0.06B | +17.94% |
| 2017-12-31 | $0.31B | +$0.04B | +16.70% |
| 2016-12-31 | $0.27B | +$0.03B | +10.71% |
Compare revenue vs peers
Medical - DevicesCompare CLVSF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income CellaVision AB (publ) receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
CellaVision AB (publ) reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in SEK.
Data sourced from CellaVision AB (publ)'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CLVSF revenue · 4 questionsCLVSF's trailing twelve-month (TTM) revenue is $0.73B. That is an increase of 4.94% year-over-year from $0.76B in FY2025.
▸ Source: FMP · CellaVision AB (publ) SEC filings · GAAP · CellaVision AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026